Betrixaban
Betrixaban (PRT054021) is a selective, reversible factor Xa inhibitor developed as an oral anticoagulant for venous thromboembolism (VTE) prophylaxis. Its research applications include in vitro enzymatic assays and in vivo models for studying thrombosis and hemostasis, particularly in contexts of restricted mobility.
Product Specifications
CAS Number
330942-05-7
Product Name Alternative
PRT 054021, PRT054021, PRT-054021, inhibit, Inhibitor, Fxa, Factor Xa, FactorXa, Betrixaban
Field of Research
Metabolism Research, Pharmacology & Drug Discovery
Purity
98.00% (May vary between batches)
Solubility
DMSO:16.67 mg/mL (36.89 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (4.43 mM)
Smiles
COc1ccc (NC (=O) c2ccc (cc2) C (=N) N (C) C) c (c1) C (=O) Nc1ccc (Cl) cn1
Molecular Formula
C23H22ClN5O3
Molecular Weight
451.91
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Explore Other Products
Browse additional items from our catalog
Anti-DRD5 Antibody Picoband®, APC Conjugate